Market guru SP Tulsian positive only on this auto stock, here's why

Stock market expert SP Tulsian of Sptulsian.com shared his views and outlook on sectors and stocks in an interview with CNBC-TV18. Tulsian is a well-known fundamental analyst with more than three decades of experience. He has an acute sense of logic and is respected for his frank and forthright views.

On pharmaceutical sector, he said, “We have been taking a very select call on pharmaceutical sector for the last three-five months and have identified  three prominent stocks amongst them – Divi’s Laboratories, Biocon and Aurobindo Pharma.

"I won’t be taking a call on the pharma sector except the select buy call on these three stocks,” he added.

With regards to auto companies, he said, “I have a call only on Maruti Suzuki India because the way they have gone for BS-VI transition and the way they have regained their market share of more than 50 percent. Once April 1 transition date comes in - if Supreme Court gives an extension that is good but if it doesn’t give an extension for BS-VI migration then that will be seen extremely positive for Maruti because they have practically seen all their variants and all the models having turned to BS-VI and then thereafter there will be a huge positive.”

“Meanwhile, for Tata Motors and Mahindra and Mahindra (M&M), the passenger vehicles (PV) and the utility vehicles (UV) have seen to be the big mess. So, will remain away from them, " he said, adding that he was not negative on the two-wheelers but would be cautious on them.

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.